Home › Funds › RTW INVESTMENTS, LP › TSHA

RTW INVESTMENTS, LP position in TSHA

TAYSHA GENE THERAPIES INC · Health Care

RTW INVESTMENTS, LP reported holding 13,560,258 shares of TSHA (TAYSHA GENE THERAPIES INC) in its Q3 2026 13F filing — a position valued at US$66.0M, representing 0.67% of its reported portfolio and ranking #42 among its reported holdings. RTW INVESTMENTS, LP has disclosed TSHA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)13.56M sh
Reported value held$66.04M
Portfolio Weight0.67%
First reportedQ3 2023
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How RTW INVESTMENTS, LP's TSHA position evolved

RTW INVESTMENTS, LP first disclosed a stake in TSHA in Q3 2023 at 16,893,185 shares (US$53.4M). The position peaked in Q2 2026 at 13,560,258 shares, worth US$92.3M. Across 13 filings, RTW INVESTMENTS, LP increased the stake 4 time(s), trimmed it 6 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 13,560,258 shares valued at US$66.0M. Notable position changes include a 42% trim in Q4 2024 (shares fell 20% over the following quarter), a 117% increase in Q1 2025 (shares rose 66% over the following quarter), a 33% increase in Q2 2025 (shares rose 42% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 16.89M $53.38M New
Q4 2023 16.89M $29.90M Hold
Q1 2024 18.59M $53.36M Add
Q2 2024 18.80M $42.11M Add
Q3 2024 14.95M $30.04M Reduce
Q4 2024 8.67M $15.00M Reduce
Q1 2025 18.79M $26.12M Add
Q2 2025 25.02M $57.80M Add
Q3 2025 24.35M $79.64M Reduce
Q4 2025 16.40M $90.19M Reduce
Q1 2026 13.68M $61.15M Reduce
Q2 2026 13.56M $92.35M Reduce
Q3 2026 13.56M $66.04M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TSHA and 13F data

TSHA (TAYSHA GENE THERAPIES INC) is a Health Care company. 47 other funds we track also report a position in TSHA — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$160.4M), Vestal Point Capital, LP (US$132.2M), Avoro Capital Advisors LLC (US$116.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TSHA

All TSHA fund holders →

FAQ

How long has RTW INVESTMENTS, LP held TSHA?

RTW INVESTMENTS, LP has disclosed TSHA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is RTW INVESTMENTS, LP's current position in TSHA?

As of Q3 2026, RTW INVESTMENTS, LP holds 13.56M shares of TSHA (TAYSHA GENE THERAPIES INC), valued at $66.04M, representing 0.67% of its reported portfolio and ranking #42.

Has RTW INVESTMENTS, LP been buying or selling TSHA?

In the latest 13F filing (Q3 2026), RTW INVESTMENTS, LP held unchanged its position in TSHA. The position peaked in Q2 2026 at 13.56M shares.

Which other funds hold TSHA?

Other major institutional holders of TSHA include RA CAPITAL MANAGEMENT, L.P., Vestal Point Capital, LP, Avoro Capital Advisors LLC, among 47 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.